Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2016 Dec 6:25:210.
doi: 10.11604/pamj.2016.25.210.9799. eCollection 2016.

The validity of the biological eligibility criteria to antiretroviral treatment in comparison to the systematic antiretroviral treatment in a cohort of people living with the HIV in the Southern Kivu Province, Democratic Republic of the Congo

Ildefonse Muzaliwa  1 , Nancy Francisca Isia  2 , Dady Yenga  3 , Denis Kikobya  1 , Prince Lunjwire  4 , Philippe Bianga Katchunga  5
Affiliations
Comparative Study

The validity of the biological eligibility criteria to antiretroviral treatment in comparison to the systematic antiretroviral treatment in a cohort of people living with the HIV in the Southern Kivu Province, Democratic Republic of the Congo

Ildefonse Muzaliwa et al. Pan Afr Med J. .

Abstract

Introduction: The late screening of the majority of patients in sub Saharan region would justify a systematic antiretroviral treatment without breaking the country programs vision. he objective of this study was to determine the validity of biological eligibility criteria to antiretroviral treatment compared with systematic antiretroviral treatment in a cohort of the people living with HIV in Bukavu city.

Methods: One thousand hundred and forty-nine (1149) records of people living with HIV (PLWIV) followed in three HIV health care facilities of Bukavu city were selected systematically. The ROC curve was constructed and analyzed to assess the validity of systematic antiretroviral therapy and a treatment based on WHO biological criteria.

Results: The CD4 median count was 196 /mm3. On admission, only 17.3% of PLWHIV had a CD4≥500/mm3. Compared to the criteria "systematic antiretroviral treatment", biological eligibility criteria for antiretroviral therapy, had a sensitivity of 94.9%, a specificity of 100%, an AUC of 0.97 (0.96 to 0.98) (p <0.0001) and correlation coefficient of 0.88.

Conclusion: This study shows that a systematic antiretroviral treatment of seropositive patients newly detected for the HIV in sub-Saharan Africa area must be requirement outwards WHO current recommendations. Also, in order to optimize expected outcome of a systematic treatment, a systematic screening in the high-risk groups of this area should be recommended.

Keywords: Treatment; antiretroviral; immunodeficiency; southern Kivu province; systematic; virus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. ONUSIDA. Fiche d’information. 2015 http://www.unaids.org/sites/default/files/media_asset/20150901_FactSheet....
    1. Timothy Sterling R, Richard Chaisson E, Richard Moore D. HIV-1 RNA, CD4T-lymphocytes, and clinical response to highly activeantiretroviral therapy. AIDS (London, England. 2001;15(17):2251–7. - PubMed
    1. Frank Palella J, Kathleen Delaney M, Anne Moorman C, Mark Loveless O, Jack Fuhrer, Glen Satten A, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–860. - PubMed
    1. Patrick Yeni G, Scott Hammer M, Charles Carpenter CJ, David Cooper A, Margaret Fischl A, Jose Gatell M, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA. 2002;288:222–235. - PubMed
    1. WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva, Switzerland: WHO; 2015. - PubMed

Substances